+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antibody Drug"

Fc Fusion Therapeutics Market by Target Indications, Type of Fusion Molecule, Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030 - Product Thumbnail Image

Fc Fusion Therapeutics Market by Target Indications, Type of Fusion Molecule, Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030

  • Report
  • September 2021
  • 150 Pages
  • Global
From
Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd edition), 2021-2030 - Product Thumbnail Image

Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd edition), 2021-2030

  • Report
  • July 2021
  • 290 Pages
  • Global
From
Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030 - Product Thumbnail Image

Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030

  • Report
  • April 2019
  • 850 Pages
  • Global
From
Cytotoxic Drugs and HPAPI Manufacturing Market by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of Highly Potent Finished Dosage Form, and Key Geographies, Europe, Asia-Pacific and Rest of the World: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Cytotoxic Drugs and HPAPI Manufacturing Market by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of Highly Potent Finished Dosage Form, and Key Geographies, Europe, Asia-Pacific and Rest of the World: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • October 2022
  • 338 Pages
  • Europe, Global, Asia Pacific Europe, Global, Asia Pacific
From
HPAPI and Cytotoxic Drugs Manufacturing Market (3rd Edition), 2020-2030 - Product Thumbnail Image

HPAPI and Cytotoxic Drugs Manufacturing Market (3rd Edition), 2020-2030

  • Report
  • February 2020
  • 304 Pages
  • Global
From
21st Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production - Product Thumbnail Image

21st Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

  • Report
  • April 2024
  • 505 Pages
  • Global
Oncology Precision Medicine Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Cancer Targeted, Route of Administration, Type of Molecule, Drug Class, Key Geographical Regions, Leading Drug Developers and Sales Forecast - Product Thumbnail Image

Oncology Precision Medicine Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Cancer Targeted, Route of Administration, Type of Molecule, Drug Class, Key Geographical Regions, Leading Drug Developers and Sales Forecast

  • Report
  • February 2024
  • 468 Pages
  • Global
From
Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030 - Product Thumbnail Image

Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030

  • Report
  • January 2019
  • 230 Pages
  • Global
From
Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication Material, Type of Bioprocess, Type of Biologic, and Key Geographical Regions - Product Thumbnail Image

Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication Material, Type of Bioprocess, Type of Biologic, and Key Geographical Regions

  • Report
  • May 2024
  • 224 Pages
  • Global
From
Monoclonal Antibody Discovery and Analysis Market Report 2022-2032 - Product Thumbnail Image

Monoclonal Antibody Discovery and Analysis Market Report 2022-2032

  • Report
  • December 2022
  • 437 Pages
  • Global
From
PSMA - Targeted Therapy Pipeline Review - Product Thumbnail Image

PSMA - Targeted Therapy Pipeline Review

  • Report
  • May 2025
  • Global
From
CCR8-Targeted Antibody Immunotherapy Pipeline Review - Product Thumbnail Image

CCR8-Targeted Antibody Immunotherapy Pipeline Review

  • Report
  • May 2025
  • Global
From
Mesothelin-Targeted Immunotherapy Pipeline Review - Product Thumbnail Image

Mesothelin-Targeted Immunotherapy Pipeline Review

  • Report
  • May 2025
  • Global
From
Folate Receptor alpha (FRa) Targeted Therapy Pipeline Review - Product Thumbnail Image

Folate Receptor alpha (FRa) Targeted Therapy Pipeline Review

  • Report
  • May 2025
  • Global
From
IGF-1R- and IGF-1 Targeted Immunotherapy Pipeline Review - Product Thumbnail Image

IGF-1R- and IGF-1 Targeted Immunotherapy Pipeline Review

  • Report
  • May 2025
  • Global
From
2024 Sales of Therapeutic Antibodies, Proteins, Biosimilars, Gene & Cell Therapy and Therapeutic RNA - Product Thumbnail Image

2024 Sales of Therapeutic Antibodies, Proteins, Biosimilars, Gene & Cell Therapy and Therapeutic RNA

  • Report
  • March 2025
  • 84 Pages
  • Global
From
Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry Perspective - Product Thumbnail Image

Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry Perspective

  • Report
  • August 2023
  • 267 Pages
  • Global
From
ROR1-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis - Product Thumbnail Image

ROR1-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

  • Report
  • June 2022
  • 115 Pages
  • Global
From
Claudin 6: A Target Opportunity To Develop Effector-Enhanced Drug Modalities - Product Thumbnail Image

Claudin 6: A Target Opportunity To Develop Effector-Enhanced Drug Modalities

  • Report
  • May 2022
  • 50 Pages
  • Global
From
Cadherin 17: A Target Opportunity To Develop Effector-Enhanced Drug Modalities - Product Thumbnail Image

Cadherin 17: A Target Opportunity To Develop Effector-Enhanced Drug Modalities

  • Report
  • May 2022
  • 32 Pages
  • Global
From
Loading Indicator

The Antibody Drug market is a subset of the biotechnology industry that focuses on the development and commercialization of therapeutic antibodies. Antibody drugs are used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. These drugs are designed to target specific molecules in the body, such as proteins, hormones, and enzymes, and can be used to block or activate certain pathways. Antibody drugs are typically administered intravenously or subcutaneously, and can be used in combination with other drugs or therapies. The Antibody Drug market is highly competitive, with many companies investing in research and development to create new and improved treatments. Companies in the market are focused on developing novel antibodies, as well as improving existing treatments. Additionally, companies are investing in the development of biosimilars, which are generic versions of existing antibody drugs. Some companies in the Antibody Drug market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, Regeneron, Roche, and Sanofi. Show Less Read more